SoftBank Group (9984) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Nov, 2025Executive summary
Net income reached ¥421.8 billion in Q1 FY2025, a significant turnaround from a loss of ¥174.3 billion a year ago, driven by strong Arm share performance, Vision Fund gains, and investment activity in OpenAI.
NAV rose to ¥32.4 trillion, up ¥6.7 trillion quarter-on-quarter, with LTV improving to 17.0% and a strong cash position despite major investments.
Strategic focus on AI, leveraging investments in Arm and OpenAI as primary growth drivers, with robust capital recycling and innovation.
Vision Fund portfolio showed strong recovery, with notable IPOs and positive investment returns.
Comprehensive income was negative ¥96.7 billion, mainly due to foreign exchange translation losses from yen appreciation.
Financial highlights
Net sales: ¥1,820.3 billion (+7.0% YoY); net income: ¥421.8 billion (vs. loss of ¥174.3 billion YoY); EPS: ¥291.71.
Income before income tax: ¥689.9 billion, up ¥464.2 billion year-on-year.
NAV: ¥32.4 trillion as of June 30, 2025, up from ¥25.7 trillion at March 31, 2025.
Loan-to-value improved to 17%, maintaining a stable financial base.
Cash and cash equivalents increased to ¥4,186.0 billion.
Outlook and guidance
Arm Q2 FY2025 revenue expected at $1.01–$1.11 billion, implying 19.7%–31.5% year-on-year growth.
Non-GAAP fully diluted EPS for Arm forecasted at $0.29–$0.37 for Q2 FY2025.
OpenAI's ARR projected to reach $12 billion, up from $5.5 billion in December 2024.
Project Stargate maintains a ¥500 billion investment target over four years, with ongoing site selection and construction.
Dividend forecast maintained at ¥44.00 per share for the fiscal year.
Latest events from SoftBank Group
- Net income soared 398.7% on investment gains and strategic AI expansion, led by OpenAI.9984
Q3 202612 Feb 2026 - A $3B joint venture launches to deploy advanced enterprise AI agents in Japan and beyond.9984
Partnership3 Feb 2026 - Net income surged to ¥636.2B on investment gains, Arm growth, and strong financial discipline.9984
Q3 20253 Feb 2026 - First profit in four years, fueled by record investment gains and major AI commitments.9984
Q4 20253 Feb 2026 - AI-powered precision medicine launches in Japan, targeting 1M annual genomic tests and data-driven care.9984
Status Update3 Feb 2026 - Shareholder value hit JPY 34T, Arm led growth, and all proposals passed amid an ASI vision.9984
AGM 20243 Feb 2026 - Record NAV, Arm's record revenue, and Vision Fund 1 gains highlight robust AI-driven results.9984
Q1 20252 Feb 2026 - Net income surged to ¥1,005.3B, led by Vision Fund, T-Mobile, and Arm's record sales.9984
Q2 202515 Jan 2026 - AI-driven demand, advanced chip designs, and ecosystem partnerships fuel strong growth.9984
Investor Update1 Dec 2025